CVRdatabase
Menu

Actabio ApS

Private limited companyCVR 26025338RoskildeActive

Actabio ApS is a private limited company, based in Roskilde, active in research and experimental development on natural sciences and engineering, founded in 2001. Equity was negative at the end of 2025 (−DKK 397k). The company made a loss in both 2024 and 2025, most recently DKK 80,533.

Follow
PDF reportCompare

Key figures · financial year 2025

RevenueDKK 12,375
Net profit−DKK 80,533−4.8% vs. 2024
Equity−DKK 397k−25.5% vs. 2024
Employees2latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • The loss grew: from DKK 76,814 to DKK 80,533 (2024 → 2025).

Registrations, last 24 months

  • 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2020–2025 · amounts in DKK thousand

Equity and net profit

−DKK 400k−DKK 350k−DKK 300k−DKK 250k−DKK 200k−DKK 150k−DKK 100k−DKK 50,000DKK 0202020212022202320242025
EquityNet profit
Financial figures for Actabio ApS
202020212022202320242025Change
Revenue127872264012–
Gross profit5528−2227−49−48+2.4%
Operating profit (EBIT)−25−30−92−57−77−81−4.8%
Profit before tax−25−30−92−57−77−81−4.8%
Net profit−25−30−92−57−77−81−4.8%
Total assets3289223114−55.6%
Equity−60−90−182−240−316−397−25.5%
Liabilities9298192261347411+18.3%
Cash and cash equivalents155921914+50.3%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report.

Download the figures as CSV · free with an account, amounts in whole DKK

−DKK 200kDKK 0DKK 200kDKK 400kDKK 600kDKK 800k202020212022202320242025
Gross profitMedian, the industry (431 companies)

Signals from the financial statements

calculated from the 2025 figures

  • Negative equity

    Equity was −DKK 397k at the end of 2025.

    How is this calculated?

    Equity in the latest annual report is below zero.

  • Loss for 6 years in a row

    Net result has been negative in 2020–2025.

    How is this calculated?

    Net result is negative in the two or more latest annual reports in a row.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

6 financial years
Annual reports for Actabio ApS
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202526/06/2026The companyPDF not statedXBRL
202401/01/2024 – 31/12/202423/06/2025The companyPDF not statedXBRL
202301/01/2023 – 31/12/202326/06/2024The companyPDF not statedXBRL
202201/01/2022 – 31/12/202230/06/2023The companyPDF not statedXBRL
202101/01/2021 – 31/12/202126/06/2022The companyPDF not statedXBRL
202001/01/2020 – 31/12/202031/05/2021The companyPDF not statedXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
011223312/1912/2012/2112/2212/2312/2411/2512/25
Employees

Position in the industry

431 companies in the database

Comparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.

Gross profit−DKK 47,652No. 266 of 421
Better than 37% of the companies in the industry
Equity−DKK 397kNo. 326 of 431
Better than 24% of the companies in the industry
Number of employees2No. 290 of 431
Better than 33% of the companies in the industry

Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.

DKK 100kDKK 2.5mDKK 63.4mDKK 1.6bnDKK 13.7bn
Distribution of gross profit for 250 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with fewer than 20 employees69,967 companies in the comparison
No. 64,949of 69,742
Better than 7%
No. 65,225of 69,964
Better than 7%
Same industry and fewer than 20 employees329 companies in the comparison
No. 191of 323
Better than 41%
No. 236of 329
Better than 28%
Companies that are between 15 and 29 years old24,910 companies in the comparison
No. 23,102of 24,791
Better than 7%
No. 23,888of 24,909
Better than 4%
All companies of type ApS66,508 companies in the comparison
No. 62,407of 66,379
Better than 6%
No. 61,666of 66,505
Better than 7%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Research and experimental development on natural sciences and engineering
Gross profit
  1. Actabio ApS−DKK 47,652
  2. Carlsberg A/SDKK 40.2bn
  3. Zealand Pharma A/SDKK 9.2bn
Net profit
  1. Actabio ApS−DKK 80,533
  2. Carlsberg A/SDKK 7bn
  3. Zealand Pharma A/SDKK 6.5bn
Equity
  1. Actabio ApS−DKK 397k
  2. Carlsberg A/SDKK 30.7bn
  3. Zealand Pharma A/SDKK 14.8bn
Employees
  1. Actabio ApS2
  2. Carlsberg A/S107
  3. Zealand Pharma A/S569

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
  • Finn Thyge Okkels100%
Actabio ApS

Management

1 active registrations

Executive management

Executive management at Actabio ApS
NameRoleAppointed
Finn Thyge OkkelsDirector02/05/2001
Founders
Finn Thyge Okkels

Signing rule: Selskabet tegnes af direktionen.

Address and production units

1 active production units

Kongemarken 11
4000 Roskilde

Roskilde Municipality · Postcode 4000

Production units
Production unitAddressEmployeesP number
ACTABIO ApSKongemarken 11, 4000 Roskilde21008423977

Purpose

Selskabets formål er at besidde, købe og sælge værdipapirer, immaterielle rettigheder og materielle produkter af en hver art samt at drive forsknings-, opfindelses-, udviklings-, handels-, forretnings-, forædlings-, landbrugs-, gartneri-, bioteknologi-, medicinal-, helse-, kosmetik-, fødevare-, have-, havearkitekt-, forfatter-, journalist-, kunst-, undervisnings-, censor- og konsulentvirksomhed samt at besidde, tilvejebringe/købe og sælge patenter/intellectual property og beslægtet virksomhed.

The purpose is quoted from the register in Danish.

Changes year by year

12 registered events
20261 changeaccounts 1
  • Annual report for 2025 published
20252 changesaccounts 1 · industry 1
  • Annual report for 2024 published
  • Industry changed to Research and experimental development on natural sciences and engineering (721000)
20241 changeaccounts 1
  • Annual report for 2023 published
20231 changeaccounts 1
  • Annual report for 2022 published
20221 changeaccounts 1
  • Annual report for 2021 published
20211 changeaccounts 1
  • Annual report for 2020 published
20181 changeindustry 1
  • Industry changed to Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721900)
20081 changeownership 1
  • Finn Thyge Okkels registered as owner (100%)
20061 changename 1
  • Name changed from GRØNNE BAKKE ApS to ACTABIO ApS
20012 changesfounded 1 · management 1
  • Registered as GRØNNE BAKKE ApS
  • Finn Thyge Okkels appointed director

Related companies

Same industry in Roskilde

See all →

Same people in management

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.

View in CVRReport a correction